Introduction {#s1}
============

The M-channel is a key regulator of excitability in a variety of central and peripheral neurons (Brown and Passmore, [@B7]). At membrane potentials sub-threshold to action potential initiation slow activation of the M-current exerts a membrane potential-clamping effect and limits the ability of a neuron to fire repetitively (Brown, [@B5]). When M-channels are inhibited, either following activation of a variety of G-protein coupled receptors (see for example Brown and Constanti, [@B6]; Adams et al., [@B1]) or by direct channel block with compounds such as linopirdine and XE991 (Aiken et al., [@B2]; Wang et al., [@B46]; Zaika et al., [@B49]), this potential-clamping effect is removed and tonic firing may be readily induced. Whilst this phenomenon has been clearly demonstrated in sympathetic (Wang et al., [@B46]; Zaika et al., [@B49]), parasympathetic (Cuevas et al., [@B8]), and some central (e.g., Peters et al., [@B27]; Shen et al., [@B40]) neurons, the physiological importance of M-current activation in other neurons is less clear.

Functional M-channels and their Kv7 channel correlates have been detected at several loci in the somatosensory pathway including dorsal root ganglion (DRG) and dorsal horn (DH) neurons (Passmore et al., [@B26]; Rivera-Arconada and Lopez-Garcia, [@B32]), peripheral nerve axons (Schwarz et al., [@B38]; Lang et al., [@B14]; Sittl et al., [@B41]), and the peripheral and central terminals of primary afferents (Rivera-Arconada and Lopez-Garcia, [@B33]; Roza and Lopez-Garcia, [@B35]; Heidenreich et al, [@B12]). Whilst positive modulation of these channels by the Kv7 current enhancer retigabine produces membrane hyperpolarization and reduces excitability (Passmore et al., [@B26]; Rivera-Arconada and Lopez-Garcia, [@B32], [@B33]; Lang et al., [@B14]; Roza and Lopez-Garcia, [@B35]), the evidence for a physiologically important role from, for example, the effects of selective channel block with low concentrations of XE991 is more limited. Thus, linopirdine and XE991 produced relatively modest effects on membrane potential and excitability in somatosensory neurons in DRG (Passmore et al., [@B26]; Liu et al., [@B16]; Mucha et al., [@B22]), DH (Rivera-Arconada and Lopez-Garcia, [@B32]) and nodose ganglion (Wladyka and Kunze, [@B48]; Wladyka et al., [@B47]).

It is possible that M-channels play a more important role at the peripheral rather than the central terminals of sensory fibers, and indeed intraplantar injection of XE991 into the hindpaw produced acute pain in rats (Linley et al., [@B15]). The latter suggests that M-channels, located in cutaneous sensory endings, are important in controlling the responses of nociceptive primary afferents. We have tested this possibility using the *in vitro* skin-saphenous nerve preparation and *in vivo* wide dynamic range (WDR) neuron recording. We have examined the effect of local application of the M-channel blocker XE991 on the excitability of primary afferent fibers and the effect of intraplantar injections of XE991 on the electrical, mechanical, and thermal-evoked responses of DH neurons. We have also examined the peripheral distribution of one of the principal subunits of the M-channel (Kv7.2: Wang et al., [@B46]) using immunofluorescence. Some parts of this work have previously been published in abstract or review form (Passmore and Brown, [@B25]; Reilly et al., [@B31]; Brown and Passmore, [@B7]).

Methods {#s2}
=======

Ethical approval
----------------

This research was approved by the UCL Ethical Review Panel and undertaken in conformity with the requirements of the UK Home Office Animals (Scientific Procedures) Act of 1986.

Immunofluorescence
------------------

Sprague--Dawley rats weighing approximately 150 g were deeply anaesthetized with ketamine/xylazine hydrochloride solution (1 ml/kg, i.p., Sigma, UK) and transcardially perfused with ice-cold heparinized saline \[9% w/V NaCl (VWR, UK), 50,000 U/l Heparin (Sigma, UK)\], then 4% paraformaldehyde (EMS Diasum, USA) in phosphate-buffered saline (PBS; Sigma, UK). The hairy skin from the dorsal surface of the hind paw was removed, post fixed for 3 h with 4% paraformaldehyde in PBS, rinsed with PBS, and then cryoprotected via immersion overnight in a 30% sucrose (VWR, UK)/0.01% NaAzide (Sigma, UK)/PBS solution.

The skin was sliced into 40 μm cryosections using a freezing microtome (Leica Microsystems, Germany) and free floating sections were placed into PBS. The sections were incubated with blocking solution \[PBS containing 3% goat serum and 3% Triton® X-100 (Sigma, UK)\] then incubated overnight at 4°C with primary antibody. Skin sections were co-stained with antibodies against Kv7.2 (1:100, Neuromabs, USA) and either TRPV1 (1:1000, Abcam, UK), neurofilament H (1:1000, Neuromics, USA), peripherin (1:1000, Abcam, UK), or tyrosine hydroxylase, (1:1000, Abcam, UK). The sections were rinsed and the Kv7.2 antibody was incubated with a biotinylated secondary antibody (Sigma, UK) then Cy3 conjugated streptavidin (Sigma, UK). All other primary antibodies were detected via fluorescein (FITC)-conjugated secondary antibodies (Sigma, UK). Staining was visualized using a Leica CA TCS SP2 AOBS spectral confocal microscope (Leica, Germany). The gain, exposure time, and wavelength were optimized for the excitation and emission spectra of each fluorophor. Control experiments performed without primary antibodies did not show labelling above background.

Skin-saphenous nerve preparation
--------------------------------

The *in vitro* rat skin-saphenous nerve preparation was used to record single nerve fiber activity and has been described in detail elsewhere (Reeh, [@B30]; Zimmermann et al., [@B50]).

Sprague--Dawley rats (150--200 g) were killed by CO~2~ asphyxiation followed by cervical dislocation. The hairy skin from the dorsal surface of the hind paw was excised together with the saphenous nerve trunk, mounted corium side-up in an organ bath and continuously superfused (16 ml min^−1^) with an oxygenated modified synthetic interstitial fluid (SIF) containing (in mM): NaCl, 139; NaHCO~3~, 21; Glucose, 10; NaH~2~PO~4~, 0.6; KCl, 3.5; MgCl~2~, 1; CaCl~2~, 1.3 at pH 7.4 and a temperature of approximately 32°C.

The saphenous nerve bundle was threaded through a hole into a recording chamber containing a shallow layer of SIF where it was de-sheathed by peeling back the epineurium. The hole between the two chambers was then filled with grease and the nerve bundle overlaid with paraffin oil and teased into small filaments until single unit activity could be resolved. Single unit activity was initially determined following electrical stimulation of the nerve trunk using an isolated constant voltage stimulator (1 ms duration; Digitimer Ltd., UK) whilst the receptive fields of single fibers were identified following manual probing of the skin with a blunt glass rod.

Fibers were classified according to their conduction velocity, von Frey threshold, and response to suprathreshold force (Zimmermann et al., [@B50]). Conduction velocity was determined following stimulation of the receptive field using a Teflon-coated steel electrode (Linton Instruments, UK). Fibers conducting below 1.2 ms^−1^ were classed as unmyelinated C-fibers and those conducting between 1.2 ms^−1^ and 15.0 ms^−1^ as thinly myelinated Aδ-fibers.

The von Frey threshold was determined using a series of calibrated von Frey hairs with an uniform tip diameter of 0.8 mm (Zimmermann et al., [@B50]) and was taken as the minimum force required to elicit three or more action potentials.

Drugs were applied directly to the receptive fields of identified peripheral primary afferents by continuous perfusion (7 ml min^−1^) via a hollow Perspex cylinder or metal ring (Zimmermann et al., [@B50]). Heat ramps were generated using a Marlow temperature controller and Peltier device or by a radiant heat lamp as previously described (Zimmermann et al., [@B50]) with an interval of 5 min between successive heat ramps to limit sensitization of the response (Du et al., [@B9]).

Single fiber activity was recorded using platinum wire electrodes (Harvard Apparatus, UK) and a low-noise AC-coupled amplifier (Neurolog, Digitimer Ltd., UK), monitored continuously using a loudspeaker and oscilloscope and digitized using a CED 1401 plus interface (Cambridge Electronic Design). Data were filtered using a band-pass filter with a bandwidth between 100 Hz and 1.5 kHz and sampled between 12 and 20 kHz. Data were analyzed offline using Spike2 software (Cambridge Electronic Design).

Data are presented as mean ± SEM for all values. Statistical comparisons between pre- and post-drug responses were performed using One-Way ANOVA followed by Bonferroni\'s multiple comparison post-test.

Vagus nerve recording
---------------------

Rat vagus nerves were isolated, desheathed, and the intact nerve placed in a three-chambered bath with the partitions grease-sealed, as previously described (Marsh et al., [@B19]). The nerve was electrically stimulated via platinum electrodes placed in the proximal chamber. Electrical potentials were recorded from the central chamber with respect to the distal chamber using Ag/AgCl electrodes with DC amplification. Procaine (1 mM) and tetrodotoxin (TTX, 0.5 μM) were added to the distal chamber to block distal action potentials and convert recorded compound action potentials to monopolar form. Drugs were continuously perfused via the central chamber at a rate of 4 ml min^−1^. Experiments were performed at 20°C to minimize noise and DC drift. Data were filtered and sampled at 10 and 100 kHz, respectively, and are presented as mean ± SEM for all values. Statistical comparisons were performed using paired Student\'s *t*-test.

*In vivo* spinal cord electrophysiology
---------------------------------------

*In vivo* electrophysiological studies were performed as previously described (Urch and Dickenson, [@B45]). Briefly, animals were anaesthetized and maintained for the duration of the experiment with isofluorane (1.5--1.7%) delivered in a gaseous mix of N~2~O (66%) and O~2~ (33%). A laminectomy was performed to expose the L4--5 segments of the spinal cord. Extracellular recordings were made from ipsilateral deep DH neurons (laminae V--VI) using parylene coated tungsten electrodes (A-M Systems, USA). The neurons included in this study met the following criteria: they had a receptive field on the plantar hindpaw; they all responded with at least 50 spikes to both light touch (8 g von frey) and noxious inputs (60 g von Frey and 48°C heat); they responded to natural stimuli in a graded manner with coding of increasing intensity; they exhibited windup when repeatedly stimulated; and they were situated at a depth of \> 500 μM from the surface of the spinal cord.

A train of 16 transcutaneous electrical stimuli (2 ms wide pulses, 0.5 Hz) applied at three times the threshold current for C-fiber activation of the DH cell was delivered via stimulating electrodes inserted into the peripheral receptive field in the hindpaw. A post-stimulus time histogram (PSTH) was constructed such that responses evoked by Aβ -- (0--20 ms), Aδ -- (20--90 ms) and C-fibers (90--350 ms) were separated and quantified on the basis of latency. Responses occurring after the C-fiber latency band were taken to be the post-discharge of the cell (350--800 ms).

The center of the peripheral receptive field was also stimulated using punctate mechanical and thermal stimuli (von Frey filaments, 2, 6, 8, 15, 26, and 60 g and a water jet applied at, 35, 40, 45, and 48°C). Application of each von Frey hair was separated by a minimum interval period of 50 s. All natural stimuli were applied for a period of 10 s per stimulus. Data was captured and analyzed by a CED 1401 interface coupled to a computer running Spike 2 software (Cambridge Electronic Design; PSTH and rate functions).

Pharmacological assessment was carried out on one ipsilateral neuron only per animal. One round of testing was performed every 20 min, and consisted of a train of electrical stimuli followed by graded natural stimuli as described above. Following three consecutive stable control trials (\< 10% variation for the C-fiber-evoked response) neuronal responses were averaged to give the pre-drug control values. XE991 (Tocris Bioscience, UK) was dissolved in 0.9% saline solution at a concentration of 200 μM, and administered via intraplantar injection close to the hindpaw receptive field. This concentration has previously been shown to induce nociceptive behavior (Linley et al., [@B15]). Intraplantar saline alone does not alter responses in this preparation (Elmes et al., [@B10]). The effect of the drug was followed for an hour, with tests carried out at 10, 30, and 50 min. The value of greatest change from the baseline for each response (electrical stimuli, natural stimuli) was then found. Two-Way ANOVA with Bonferroni\'s multiple comparison post-test was used to compare pre-dose baselines with greatest change from baseline values for each natural response, while paired Student\'s *t*-test was used to compare pre-and post-dose electrically evoked responses.

Results {#s3}
=======

Kv7.2 is expressed in nociceptive sensory endings
-------------------------------------------------

Since Kv7.2 is present in small diameter DRG neurons, and functional M-currents can be recorded from DRG neurons in both culture and slice preparations (Passmore et al., [@B26]; Rose et al., [@B34]), we hypothesized that it might also be expressed at cutaneous sensory endings.

We examined Kv7.2 expression in cryosections from rat hairy skin. Kv7.2 was detected in both myelinated and unmyelinated nerve bundles (Figure [1](#F1){ref-type="fig"}, panels **A--F**), as indicated by co-staining for neurofilament H and peripherin, respectively. Some Kv7.2 positive fibers also expressed TRPV1 (Figure [1](#F1){ref-type="fig"}, panels **G--I**), a marker of nociceptive nerve bundles. Kv7.2 also co-localized with tyrosine hydroxylase (Figure [1](#F1){ref-type="fig"}, panels **J--L**) indicating expression in sympathetic fibers as expected (Hadley et al., [@B11]).

![**Kv7.2 in rat cutaneous sensory endings. (A--L)** Rat hairy skin sections stained with antibodies against Kv7.2 (red). Pictures show Kv7.2 localization in myelinated fibers (**A--C**, counterstained for neurofilament **H**), unmyelinated fibers (**D--F**, counterstained for peripherin), nociceptive fibers (**G--I**, counterstained for TRPV1), and sympathetic fibers (**J--L**, counterstained for tyrosine hydroxylase). Scale bar, 20 μM in panels **A--C**, **G--I**, and **J--L**, 10 μM in panels **D--F**.](fnmol-05-00063-g0001){#F1}

Interestingly, not all fibers of each of these fiber classes stained for Kv7.2, witness the neurofilament H-positive/Kv7.2-negative bundle in panel **C** and the peripherin-positive/Kv7.2-negative fibers within the fiber bundle in panel **F**.

Nociceptive sensory endings express functional M-channels
---------------------------------------------------------

To determine whether functional M-channels are present at nociceptive sensory nerve endings in the skin we used an *in vitro* skin-saphenous nerve preparation to examine the single unit responses of identified Aδ- and C-fibers to noxious heat stimulation under control conditions and in the presence of the M-channel modulators retigabine and XE991.

Two or more (up to four) control heat ramps were applied prior to drug application to determine whether any sensitization/desensitization of the response occurred from repeated heat stimulation. Drugs were applied once the response began to stabilize.

Figure [2](#F2){ref-type="fig"} shows an example of the experimental approach used. The response of a mechano-heat Aδ-fiber (AMH) is shown from which it is clear that the number of action potentials elicited in response to a heat ramp from 30°C to 44°C (top panels in Figure [2A--F](#F2){ref-type="fig"}) was altered following exposure of the receptive field to the M-channel modulators retigabine and XE991, respectively. Under control conditions the heat ramp induced a robust firing response (Figure [2A](#F2){ref-type="fig"}), which was inhibited following exposure of the receptive field to 10 μM retigabine for 5 min (Figure [2B](#F2){ref-type="fig"}), but recovered during washing (Figures [2C](#F2){ref-type="fig"} and [D](#F2){ref-type="fig"}). Application of XE991 (3 μM) to the receptive field produced a marked sensitization to the subsequent heat stimulation and induced spontaneous firing at 30°C (Figure [2E](#F2){ref-type="fig"}). After 20 min of washing, the response recovered toward that seen in control (Figure [2F](#F2){ref-type="fig"}).

![**Cutaneous sensory endings express functional M-channels. (A--F)** Example of a mechano-heat (AMH) Aδ-fiber response to noxious heat stimulation pre- and post-exposure to the M-channel modulators retigabine and XE991. Top panels in **A--F** show the noxious heat ramps that ramp from 30°C to 44°C. Control response **(A)**, 10 μM retigabine **(B)**, 5 min wash **(C)**, 10 min wash **(D)**, 3 μM XE991 **(E)**, and 20 min wash **(F)**. (The apparent decline in action potential amplitude from **A** through **F** probably results from drying-out of the nerve following prolonged immersion in liquid paraffin.)](fnmol-05-00063-g0002){#F2}

M-channel opening dampens Aδ- and C-fiber responses to noxious heat
-------------------------------------------------------------------

We examined the effect of retigabine on the responses of a further six AMH-fiber responses. Five minutes\' exposure of the receptive fields to 10 μM retigabine produced a significant (*P* \< 0.005) inhibition of AMH-fiber responses to noxious heat (Figure [3A](#F3){ref-type="fig"}). It reduced the mean number of action potentials per heat stimulation from 58.6 ± 15.8 and 52.3 ± 13.3 in two control ramps, respectively, to 21.7 ± 12.9 at 5 min and to 7.3 ± 3.6 at 10 min after application. The effect of retigabine was relatively persistent and irreversible over 15 min in four of the seven fibers; the other three fibers began to recover after 10--15 min washing, the mean number of action potentials per heat stimulation for all seven fibers increasing to 9.1 ± 6.1 and 15.5 ± 10.8, respectively. In spite of this persistent reduction in activity, fibers could still either be electrically stimulated or responded to noxious heat following exposure of their receptive fields to 3 μM XE991, as in Figure [2](#F2){ref-type="fig"}.

![**Opening M-channels in sensory endings with retigabine (RET) strongly dampens AMH-fiber responses to noxious heat but has less effect on C-fibers.** Normalized responses to noxious heat in AMH-fibers **(A)** and C-fibers (**B** and **C**). Normalization is to the mean of the two control responses prior to retigabine exposure. AMH-fiber responses were significantly inhibited by 10 μM retigabine (^\*^*P* \< 0.05, ^\*\*^*P* \< 0.01, ^\*\*\*^*P* \< 0.005). **(C)** C-fiber minimal responses to heat measured at either 5 or 10 min following exposure to retigabine were significantly reduced (^\*^*P* \< 0.05) compared to control. Number of fibers shown in brackets. AMH- and C-fiber mean conduction velocities were 3.98 ± 0.99 ms^−1^ (*n* = 7) and 0.65 ± 0.09 ms^−1^ (*n* = 10), respectively.](fnmol-05-00063-g0003){#F3}

In contrast, retigabine had much less effect on C-mechano-heat (CMH)/C-mechano-cold-heat (CMCH) fiber responses to noxious heat. A pooled time-plot (Figure [3B](#F3){ref-type="fig"}) did not reveal a significant reduction in response (*n* = 10; *P* \> 0.05) as determined by ANOVA followed by Bonferroni\'s or Tukey\'s multiple comparison post-tests; the mean number of action potentials per heat stimulation were 39.8 ± 7.6 and 36.8 ± 7.2 in two control ramps, respectively, 26.6 ± 8.8 at 5 min and 23.0 ± 6.8 at 10 min after retigabine application, and 32.6 ± 13.7 after 10 min washing. However, to some extent this apparently-weak effect may have been due to variations in the time course of retigabine action on individual C-fibers, since the minimal response of the fibers after retigabine application (measured at either time-point within the 10 min period after application) was significantly reduced to 20.8 ± 7.2 action potentials per heat stimulation (*P* \< 0.05; Figure [3C](#F3){ref-type="fig"}). Notwithstanding, the effect of retigabine on the C-fiber responses was clearly smaller and less convincing than that on Aδ fibers.

M-channels regulate Aδ-fiber but not nociceptive C-fiber responses to noxious heat
----------------------------------------------------------------------------------

The marked sensitization to heat produced by XE991 (Figure [2E](#F2){ref-type="fig"}) suggests that M-channels may play a pivotal role in the physiological regulation of action potential initiation at the primary afferent ending. We examined this further by testing the effects of XE991 on the responses of 32 Aδ- and 8 C-fibers to noxious heat.

The most striking effect was the sensitization of "apparent" heat insensitive Aδ-mechano (AM) fibers to heat (Figures [4A--C](#F4){ref-type="fig"}). Five minutes\' exposure of the receptive fields of 15 AM-fibers to 3 μM XE991 increased the mean number of action potentials per heat stimulation from 0.5 ± 0.3 and 0.2 ± 0.1 in two controls, respectively, to 130.4 ± 50.2 at 5 min after application. The effect of XE991 was persistent, the mean number of action potentials increasing to 201.9 ± 82.0 and 276.4 ± 111 at 10 and 15 min after application, respectively. After 20 min washing the mean number of action potentials reduced to 84.9 ± 31.1 per heat stimulation. As illustrated in Figure [2E](#F2){ref-type="fig"}, 10 of the 15 fibers exhibited spontaneous activity at 30--32°C following exposure of their receptive fields to 3 μM XE991. Ongoing activity at 32°C in the absence of a response to noxious heat was also seen in an additional AM-fiber following exposure of its receptive field to 3 μM XE991. In contrast, 6 AM-fibers (out of a total of 32 sampled) were insensitive to XE991; exposure of their receptive fields to 3 μM XE991 failed to sensitize these fibers to noxious heat and no ongoing activity at 32°C was observed. However, these fibers developed responses to noxious heat following exposure of their receptive fields to 20 mM KCl (data not shown).

![**M-channel inhibition sensitizes Aδ-fibers to subsequent heat stimulation.** An AM-fiber that is unresponsive to noxious heat in control **(A)** fires action potentials in response to noxious heat following exposure of its receptive field to 3 μM XE991 **(B)** The top panels in **A** and **B** show the noxious heat ramps that ramp from 31°C to 48°C. An expanded time scale of the activity is shown in **C. (D)** Normalized responses to noxious heat in AMH-fibers. Normalization is to the mean of the two control responses prior to XE991 exposure. **(E)** AMH-fiber peak response. Peak responses to heat following exposure to XE991 are significantly increased (^\*^*P* \< 0.05) compared to control. Number of fibers shown in brackets. AMH-fiber mean conduction velocity was 6.93 ± 1.5 ms^−1^ (*n* = 10).](fnmol-05-00063-g0004){#F4}

XE991 also produced modest increases in the responses of 10 AMH-fibers to noxious heat (Figures [4D](#F4){ref-type="fig"} and [E](#F4){ref-type="fig"}). The effect of XE991 was delayed in 6/10 fibers, the peak firing response occurring at 10--15 min after exposure. 3 μM XE991 significantly (*P* \< 0.05) increased the number of action potentials from 12.6 ± 3.9 and 5.6 ± 1.0 in two controls, respectively, to a peak response of 46.8 ± 8.

In contrast to the sensitizing effect of XE991 on Aδ-fiber responses to noxious heat, 3 μM XE991 had negligible effect on the responses of 7 out of 8 C-fibers tested (Figure [5](#F5){ref-type="fig"}). Five minutes\' exposure of the receptive fields of 5 C-fibers (4 CMH, 1 CMCH) to 3 μM XE991 had no significant effect compared with control (*P* \> 0.05; Figure [5H](#F5){ref-type="fig"}). The mean number of action potentials per heat stimulation was 47 ± 32.5 and 35.2 ± 23.0 in two controls, respectively, and 35 ± 24.4 at 5 min after exposure to XE991. In 3/8 C-fibers (2 CMH, 1 CMCH), the receptive fields were exposed for an additional 5 min. XE991 had no effect on the responses of the two CMH-fibers but recruited the CMCH-fiber during cooling from noxious heat so that it began firing robustly at 40.8°C compared with 31.2°C in control (data not shown). This latter observation was not investigated further due to the rarity of CMCH-fibers in rat hairy skin (Zimmermann et al., [@B50]).

![**M-channel inhibition does not sensitize C-fibers to subsequent heat stimulation. (A--F)** 3 μM XE991 does not facilitate the response of a CMH-fiber (small fiber) but recruits an Aδ-fiber (large fiber) that was unresponsive to heat stimulation in control. The top panels in **A**, **C,** and **F** show the noxious heat ramps that ramp from 30°C to 48°C. **(E)** Profile of the Aδ- and C-fiber on an expanded time-scale. **(B, D,** and **G)**. Activities of the fibers on an expanded time-scale in control, XE991 and following 10 min wash. **(H)** Normalized responses to noxious heat in C-fibers. Normalization is to the mean of the two control responses prior to XE991 exposure. Although the response at 20 min is significantly lower (^\*^; *n* = 5; *P* \< 0.05) than that in the first control, this may have resulted from a rundown of the response with repeated stimuli, which we observed in some C-fiber recordings, rather than an effect of XE991. Number of fibers shown in brackets. C-fiber mean conduction velocity was 0.55 ± 0.13 ms^−1^ (*n* = 5).](fnmol-05-00063-g0005){#F5}

M-channels in unmyelinated fibers?
----------------------------------

The above results raise the question whether unmyelinated fibers in general possess functional M-channels. We tested this using rat vagus nerves in which around 80% of the fibers are unmyelinated (Soltanpour and Santer, [@B42]). As shown in Figure [6A](#F6){ref-type="fig"}, retigabine (10 μM) consistently hyperpolarized the nerve in the central chamber with respect to the reference electrode in the distal chamber (mean axonal polarization = 0.38 ± 0.022 mV, *n* = 33). This was significantly reduced by 30 μM linopirdine (from 0.42 ± 0.04 to 0.19 ± 0.02; *n* = 11, *P* \< 0.005) or by 10 μM XE991 (from 0.33 ± 0.03 to 0.09 ± 0.02 mV; *n* = 7, *P* \< 0.01) (Figure [6C](#F6){ref-type="fig"}), showing that it resulted from increased M-channel activity. Although the nerve contains both A and C fibers, the hyperpolarization was generated, at least in part, in the C-fibers, since the evoked C-fiber compound action potential was enhanced and the post-spike hyperpolarization reduced (Figure [6B](#F6){ref-type="fig"}), as expected were the membrane potential shifted nearer to *E*~K~. However, as is apparent from Figure [6A](#F6){ref-type="fig"}, linopirdine did not materially increase the resting demarcation potential, i.e., it did not depolarize the C-fibers. Thus, the maximum increases in demarcation potential produced by 10--30 μM linopirdine and 10 μM XE991 were only 0.071 ± 0.015 mV (*n* = 10) and 0.048 ± 0.016 mV (*n* = 6), respectively. Further, since all these preparations had previously been exposed to retigabine, it is likely that even this small response was due to block of residual retigabine-enhanced M-currents, not unmodified currents.

![**Retigabine-induced a linopirdine-sensitive hyperpolarization of the rat vagus nerve with concomitant changes in the compound action potential generated by the unmyelinated axons (C-spike). (A)** 10 μM retigabine applied for 3 min induced a prolonged hyperpolarization of the vagus nerve that was reversibly inhibited by 30 μM linopirdine. Hyperpolarization was recorded as the change in surface demarcation potential between the central drug-perfused chamber and the distal chamber containing the cut nerve ending. **(B)** The C-spike compound action potential amplitude (second deflection) was increased and the spike after-hyperpolarization was decreased by retigabine (red trace). Data has been baseline subtracted for ease of comparison. **(C)** Mean (± SEM) demarcation potential changes produced by retigabine. The retigabine-induced hyperpolarization (black columns) was reproducible when reapplied after 1 h (first pair, open column; *n* = 8) and significantly inhibited when the second application was preceded by 10 μM XE991 (second pair, *n* = 7; ^\*\*^*P* \< 0.01) or 30 μM linopirdine (third pair, *n* = 11 ^\*\*\*^*P* \< 0.005).](fnmol-05-00063-g0006){#F6}

*In vivo* evidence for peripheral M-channel modulation of sensory function
--------------------------------------------------------------------------

In order to further characterize the physiological role of M-channels in peripheral sensory terminals, extracellular action potentials were recorded from deep DH neurons with receptive fields on the plantar hindpaw. These neurons were characterized as wide dynamic range cells (WDR), in that they gave a graded response to a wide range of innocuous and noxious mechanical and thermal stimuli, exhibited windup, and were located in laminae V--VI of the DH, as previously described (e.g., Bee et al., [@B4]).

Intraplantar XE991 (200 μM) had no significant effect on electrically-evoked responses, where stimulation is delivered directly to peripheral nerve endings, bypassing mechanical and thermal transduction mechanisms (Figure [7](#F7){ref-type="fig"} panels **A** and **B**, paired *t*-test of predose baseline against maximum change in post-dose hour of recording).

![**Effect of intraplantar (iplan) XE991 (200 μM) on evoked electrical, mechanical, and thermal responses in deep dorsal horn wide dynamic range (WDR) neurons.** While XE991 had no significant effect on electrically-evoked responses (**A** and **B**) nor brush-evoked responses **(E),** low-medium range mechanical **(C)** with expanded view of low range von Frey responses in **(D)** and high range thermally evoked responses **(F)** were all potentiated (for electrical stimuli: paired *t*-test of pre- vs. greatest change post-dose values; for natural stimuli: Two-Way ANOVA with Bonferroni\'s post-test of pre- vs. post-dose responses, ^\*^*P* \< 0.05, *n* = 8 WDR cells). See Methods for technical details.](fnmol-05-00063-g0007){#F7}

Spinal WDR cell responses to von Frey hairs applied to the hindpaw receptive field were selectively potentiated. The responses to 6, 8, and 15 g von Frey hairs were significantly potentiated, while responses to the upper range of mechanical stimuli and to innocuous brush were not significantly altered (Figure [7](#F7){ref-type="fig"} panel **C**, with expanded view of low range von Frey responses and brush response in panels **D** and **E**, respectively. Two-Way ANOVA with Bonferroni\'s multiple comparison post-test, *n* = 8 WDR cells).

Contrastingly, spinal WDR cell responses to thermal stimuli (water jet applied to the hindpaw receptive field) were significantly potentiated in the higher thermal range (Figure [7](#F7){ref-type="fig"} panel **F**, 48°C; Two-Way ANOVA with Bonferroni\'s multiple comparison post-test, *n* = 8 WDR cells).

No consistent effect was seen on repetitive firing immediately following application of natural stimuli. No spontaneous firing of spinal WDR cells was observed following intraplantar XE991. In contrast to the effects of XE991 delivered intraplantar, central XE991 applied directly to the spinal cord (as doses of 1 or 10 μg in 50 μl saline) did not cause significant alteration in WDR cell-evoked responses (data not shown).

These *in vivo* results corroborate the *in vitro* studies indicating a role for M-channels in physiological modulation of small afferent fibers, particularly Aδ-fibers, and extend this modulation to certain mechanosensitive as well as thermosensitive fibers.

Discussion {#s4}
==========

In these experiments we have shown the presence of an M-channel subunit in sensory nerve endings by immunohistochemistry and have demonstrated a role for M-channels in the modulation of peripheral sensory transmission by both *in vitro* and *in vivo* electrophysiological preparations.

Immunohistochemistry has revealed the presence of Kv7.2 channel protein in some (but not all) sensory nerve endings in rat paw skin. Staining was observed in both myelinated and unmyelinated fibers, and in both nociceptive (TRPV1-staining) and non-nociceptive fibers. This accords with previous observations showing Kv7.2 immunoreactivity in both small and large neurons in the DRG (Passmore et al., [@B26]). Some of the DRG neurons also stained for Kv7.3 and Kv7.5 (Passmore et al., [@B26]). We have not tested for these in the present experiments but it has recently been reported that Kv7.5 is the predominant immunoreactive M-channel subunit in small sensory neurons and in vagal C-fibers, with Kv7.2 being restricted to vagal myelinated fibers where immunoreactivity was concentrated at nodes of Ranvier (King and Scherer, [@B13]). Interestingly, the converse appear to hold for baroceptor afferents, with Kv7.2 in the unmyelinated and small myelinated fibers and Kv7.5 in the larger afferents (Wladyka et al., [@B47]). Kv7.2 immunoreactivity has also been identified in sciatic nerve nodes of Ranvier (Schwarz et al., [@B38]) and at nerve-end neuromas in axotomised saphenous nerves (Roza et al., [@B36]). In contrast, M-channels in the peripheral endings of cutaneous rapidly-adapting mechanoreceptor afferents are composed of Kv7.4 subunits (Heidenreich et al, [@B12]).

Irrespective of the particular subunit involved, we have provided clear evidence for the presence of functional M-channels in nociceptive afferent fiber endings in the skin of the rat\'s paw. Thus, the M-channel enhancer retigabine applied directly to the peripheral nerve endings consistently reduced the responses of Aδ afferent fibers to noxious heat and this effect (where tested) was reversed by the M-channel blocker XE991. Retigabine also reduced thermal responses of afferent C-fibers, though to a lesser extent. Lang et al. ([@B14]) have also shown that retigabine reduces the electrical excitability of C-fibers in human sural nerve. Using different (mechanical and inflammatory chemical) stimuli, Roza and Lopez-Garcia ([@B35]) reported that retigabine could reduce C- and Aδ-fiber responses of neuromatose skin afferents but could observe no clear effect on intact fibers. Differences from the present experiments may stem from the different stimuli used, implying perhaps a different fiber-population and/or a species difference.

These effects of retigabine confirm the presence of M-channels in nociceptive sensory nerve endings but do not show whether they affect normal physiological responses to nociceptor stimulation. This is better inferred from the effect of blocking the M-channels. In the *in vitro* skin-saphenous nerve preparation we show that the M-channel blocker XE991 consistently and substantially enhanced the Aδ-fiber response to noxious thermal stimulation without clearly affecting the C-fiber response. Despite a low number of observations, a similar facilitation of Aδ-fiber responses to mechanical stimulation after exposure to XE991 has been previously reported (Roza and Lopez-Garcia, [@B35]). Further, in *in vivo* tests we found that intraplantar injection of XE991 selectively enhanced the response of deep DH neurons to peripheral mid-range mechanical and higher-range (48°C) thermal stimuli.

While the lightest mechanical stimuli are likely to recruit mainly low threshold Aβ fibers, and the most noxious 26 and 60 g von Frey hairs are likely to recruit high threshold C-fibers, Aδ-fibers are most likely responsible for transduction and transmission of mechanical stimuli in the middle range (Martin et al., [@B20]; Lynn and Shakhanbeh, [@B17]). It has recently been demonstrated in both rat and human that, somewhat counter-intuitively, a cutaneously applied CO~2~ laser heat stimulus recruits first C-fibers, and then Aδ-fibers when its intensity is increased (Sikandar, personal communication; Mouraux et al., [@B21]). It is, therefore, likely that the potentiation of mid-range mechanical and upper range thermal-evoked responses by XE991 would be consistent with localization of M-channels primarily on Aδ-fiber peripheral terminals. This could be consistent with a preferential enhancement of peripheral Aδ-fiber discharges, also seen in the skin-saphenous nerve population. Although the concentration of XE991 used in these experiments was high (200 μM), it matches that previously found to induce acute pain by intraplantar injection (Linley et al., [@B15]); indeed, our findings provide a clear rationale for the observation of enhanced behavioral responses. Interestingly, the spectrum of effects of XE991 *in vivo* partially resemble the polymodal effects seen in TREK-1 gene-deleted mice (Alloui et al., [@B3]); like Kv7.2 (Rose et al., [@B34]), TREK-1 is strongly expressed in TRPV1-containing sensory neurons, so might co-localize with Kv7.2 in sensory nerve endings.

How might M-channels regulate sensory nerve activation by noxious stimuli? One possibility is simply that sufficient M-channels are open at rest as to generate a component of the "leak" conductance. This may slightly hyperpolarize the nerve ending but more significantly add a shunt conductance that would reduce the amplitude of the nociceptor generator potential and raise the threshold for action potential initiation. The voltage-sensitivity of the channels would then enhance their effect during sensory nerve activation. This conductance shunt has been suggested to be responsible for the effect of Kv7.4 channels on cutaneous rapidly adapting mechanoreceptor discharges. Here the channels are localized to the unmyelinated terminals of myelinated fibers in Meissner\'s corpuscles and in the hair follicles, and exert a strong effect in attenuating low-frequency mechanosensory discharges (Heidenreich et al, [@B12]).

If the effect of M-channels on nociceptor afferent discharges results from a similar conductance-shunting effect at the unmyelinated fiber terminals, why then should the Aδ-fiber discharges be more sensitive than the C-fiber discharges to XE991? One possibility is that it relates to the different Kv7 subunits reported to be present in the two fiber types (Kv7.5 in unmyelinated afferents versus Kv7.2 in myelinated afferents: King and Scherer, [@B13]), since the former appear rather less sensitive to XE991 (IC~50~ against Kv7.5 = 65 μM; Schroeder et al., [@B37]) than other Kv7 channels (IC~50~ against Kv7.2 = 0.71 μM and Kv7.2/7.3 = 0.6 μM, Wang et al., [@B46]) \[although these have not been directly compared in the same set of experiments\]. However, this seems unlikely, because the effects of retigabine on C-fiber excitability (Lang et al., [@B14]) and membrane potential (this paper, Figure [6C](#F6){ref-type="fig"}) were blocked by 10 μM XE991.

An alternative explanation might be that the M-channels are not, in fact, very active at or near the resting potential in the unmyelinated terminals of nociceptor afferents. Thus, while there is evidence that M-channels are active at resting potential in small sensory neurons (where their block produces a membrane depolarization and increases action potential discharges during depolarizing current injections: Passmore et al., [@B26]; Wladyka and Kunze, [@B48]; Wladyka et al., [@B47]; Liu et al., [@B16]) there is no direct evidence that this is so in peripheral nerve terminals. Indeed the excitability of sensory C-fibers in the sural nerve is not changed by XE991 (Lang et al., [@B14]), nor were vagal C-fibers substantially depolarized by XE991 or linopirdine, even though they were strongly hyperpolarized by retigabine and this hyperpolarization blocked by XE991 (present paper). Thus, M-channels were clearly present but normally inactive. Perhaps peripheral nociceptor terminals and unmyelinated fibers are maintained at a membrane potential negative to the activation threshold for the M-channels, for example, by electrogenic Na-pump activity (Rang and Ritchie, [@B29]) or by current flow through K2P "leak" channels or Na^+^-activated K~Na~ (Slo2) channels. Both of the latter have been reported in sensory neurons (K2P: Plant, [@B28]; Marsh et al., [@B18]; K~Na~: Tamsett et al., [@B43]; Nuwer et al., [@B23]; see also Alloui et al., [@B3]; referred to above), though whether these channels are active in terminals or unmyelinated fibers is not yet clear.

In contrast, the excitability of myelinated fibers in peripheral nerves clearly *is* increased by blocking M-channels (Schwarz et al., [@B38]; Sittl et al., [@B41]). Hence, we propose that the greater sensitivity of the Aδ-fibers to XE991 results from the fact that, in peripheral myelinated fibers, the M-channels are primarily expressed at nodes of Ranvier (Schwarz et al., [@B38]; King and Scherer, [@B13]), and also perhaps at the site of action potential initiation (Pan et al., [@B24]). At such loci, they would have a profound effect on the threshold for action potential generation and on the ability of the fibers to sustain trains of action potentials. Thus, inhibition of M-channel function at the axon initial segment of hippocampal neurons substantially lowers the action potential threshold, increases the firing frequency during neuron depolarization and can even induce spontaneous firing (Shah et al., [@B39])---in total, very like the effects of XE991 on Aδ-fiber activity.

Then how might retigabine inhibit sensory discharges under circumstances where XE991 has no effect? The main effect of retigabine is to produce a hyperpolarizing shift of some 20 mV or more in the voltage-dependence for M-channel activation (Tatulian et al., [@B44]). Hence, so long as M-channels were present, even if they were not normally very active at rest, they would now become so, and would produce a large hyperpolarization and large increase in the conductance shunt. Thus, even though C-fiber excitability is not normally enhanced by XE991, their excitability is strongly reduced by retigabine (Lang et al., [@B14]); and primary afferent fibers unresponsive to XE991 are strongly hyperpolarized by retigabine (Rivera-Arconada and Lopez-Garcia, [@B33]). In this connection, we have also noted a similar discrepancy between the effects of XE991 and retigabine with respect to the responses of DH neurons to XE991 and retigabine when applied to the spinal cord: whereas spinal cord application of retigabine strongly reduced nociceptive responses (Passmore et al., [@B26]), a similar application of XE991 in the present study had no effect. Thus, retigabine can attenuate nociceptive and other forms of hyper-excitability by enhancing M-channel activity, even at sites where the channels do not normally have a very prominent physiological role.

The present data thus demonstrate an important physiological contribution of M-channels to sensory function in the peripheral terminals of Aδ-fibers. They also suggest that these peripheral M-channels might be targeted by locally applied agents for the control of pain.
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